June 25, 2013

The healthcare industry continues to prepare for ACA implementation and the expected influx of newly eligible patients, said Emdeon's Kevin Mahoney. Many pharmacies are changing their staffing models in preparation for customers with expanded Medicaid benefits — especially as we approach the New Year. This is a good time for me to remind you to be thinking about your eligibility program.

October 3, 2012

DSN recently caught up with Sajid Syed, president of Acro Pharmaceutical Services, to talk about how the company works with what he calls the "four P's" — the patient, physician, pharmaceutical manufacturer and payer — to provide an array of specialty pharmacy services to clients.

August 24, 2011

Behind every prescription that lands at the pharmacy counter is a series of events that influence the prescriber’s decision. Powered by data from SDI Health, Drug Store News goes inside the examination room in this exclusive report, providing an in-depth look at the critical factors that shape pharmaceutical sales trends and shift market share from one drug to another in 10 key market segments.

August 28, 2014

H. D. Smith on Monday announced the winners of its annual Trading Partners of the Year award, honoring select pharmaceutical and health products manufacturers who collaborate actively to grow the industry and advance patient care.

August 27, 2014

Canadian pharmaceutical company Apotex announced the appointment of Dr. Jeremy Desai to president and CEO. He has spent close to 30 years in a number of senior roles within the pharmaceutical industry and has been with Apotex for the last 11 years.

August 27, 2014

The International Society for Pharmaceutical Engineering on Wednesday announced that it has released a preview of its Drug Shortages Prevention Plan aimed at helping the pharmaceutical industry avoid drug shortages and maintain a reliable supply of medications. 

August 25, 2014

Biotech company Roche will be acquiring research and pharmaceutical company InterMune for $8.3 billion, it announced over the weekend. 

August 20, 2014

In July, the National Association of Specialty Pharmacy and the Specialty Pharmacy Association of America announced the two organizations would merge, creating the largest professional and trade association in the specialty pharmacy industry. To find out more, DSN interviewed Larry Irene, CEO of Armada Health Care and SPAARx founder, and Gary Cohen, CEO of NASP.

August 13, 2014

The European Union is leading an international pilot project through which, upon request from a generic pharmaceutical company, it will share the assessment reports generated as part of the decentralized procedure in real time with collaborating regulatory agencies outside the EU.

August 8, 2014

Walgreens pulled the trigger on step two of its proposed Alliance Boots merger a full six months early.

 

August 6, 2014

Walgreens said it has exercised its option to complete the second step of its strategic transaction with Alliance Boots ahead of the original option period, which was between February and August 2015.

 

August 4, 2014

Cardinal Health on Monday reported fourth-quarter fiscal 2014 revenue of $23 billion, down 9.8%.

 

July 30, 2014

McKesson announced on Wednesday a three-year extension of its existing distribution agreement with CVS Caremark through June 2019.

July 29, 2014

The use of FDA drug safety programs to prevent generic competition is costing the American health care system and patients $5.4 billion in annual pharmaceutical spending.

July 21, 2014

Addressing 3,000 independent pharmacy attendees representing more than 1,000 pharmacies at the McKesson ideaShare 2014, Mark Walchirk, president of McKesson’s U.S. pharmaceutical unit outlined the myriad of opportunities open to community pharmacy today, and how McKesson is investing in its independent pharmacy offerings to help those independents realize every one of those opportunities.

July 10, 2014

As lifetime earnings for pharmaceuticals decrease, commercialization expenses increase and payers tighten their belts on reimbursement, life science companies will be faced with shrinking margins over the next few years. In order to maintain basic operating margin levels and continue investing in research and development at current levels, life science manufacturers will be forced to reduce costs by more than $35 billion by 2017, according to results from a new survey of 70 life science organizations from the IMS Institute for Healthcare Informatics.

July 1, 2014

Actavis and Forest Labs. on Monday announced that the U.S. Federal Trade Commission has voted to approve Actavis' proposed acquisition of Forest.

June 27, 2014

AmerisourceBergen on Thursday announced that it has completed the acquisition of a minority stake in Profarma Distribuidora de Produtos Farmacêuticos, a leading pharmaceutical wholesaler in Brazil.

June 27, 2014

Just two months after Labeed Diab was named head of health and wellness at Walmart, Mark Phillips was elevated to the role of VP pharmaceutical merchandising. Phillips assumes command of more than 4,175 retail pharmacy operations that generates $16.8 billion in pharmacy revenue, according to DSN's PoweRx 50. In his new role, Phillips will lead the pharmaceutical merchandising team and report to Diab. Phillips, who most recently served as the senior director of merchandising in small formats, is a long-time buyer for Walmart and may be an indication of Walmart's steadfast commitment to growing pharmacy, health and wellness, especially across Walmart's smaller formats.

June 24, 2014

The Federal Trade Commission is stepping up probes of pay-for-delay settlements — pharmaceutical deals that delay the sale of generic drugs — according to a report published Monday by Bloomberg.

June 20, 2014

Mark Phillips was elevated to the role of VP of pharmaceutical merchandising at Walmart after previously serving as the retailer’s senior director of merchandising for small formats.

June 13, 2014

Following the campaign's six-month anniversary, Fight the Fakes last week announced 11 new partners, bringing the total number of member organizations to 25.

June 13, 2014

New approaches to treating cancer are creating big growth opportunities for the pharmaceutical industry, Moody's Investors Service stated in a report released Thursday titled "Cancer Breakthroughs Bring New Options for Patients and Revenue Streams to Big Pharma."

June 10, 2014

McKesson Canada on Monday announced the appointment of its new president, Alain Champagne.